News and analysis on diagnostic technologies and applications.
The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.
The Human Diagnosis Project recently brought in partners in an effort to expand specialty care to underserved populations across the US and measure outcomes.
The company, which also said it is short on funds, may have to pay $18.3 million to Hudson Bay Master Fund if forebearance is not granted for the default.
Developers can use the Zika virus samples to ascertain whether their tests can help distinguish Zika infection from similar diseases.
Once these coverage decisions are fully implemented, 90 percent of breast cancer patients will have coverage for EndoPredict, Myriad estimated.
